Characterisation of the genomes of brain metastases
<p>Brain metastases are generally associated with a poor prognosis. The number of metastases, location and control of extracranial disease typically influences the management of patients. Treatment options are currently limited and are dependent on the clinical context. Interventions include s...
Autor principal: | Ulahannan, D |
---|---|
Outros Autores: | Tomlinson, I |
Formato: | Tese |
Publicado em: |
2015
|
Registros relacionados
-
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
por: Marcin Nicoś, PhD, et al.
Publicado em: (2022-12-01) -
Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
por: Ursula Just, et al.
Publicado em: (2024-01-01) -
Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel
por: Duna H. Barakeh, et al.
Publicado em: (2022-11-01) -
Genomic landscape of the immune microenvironments of brain metastases in breast cancer
por: Wei-cheng Lu, et al.
Publicado em: (2020-08-01) -
Prevention of Brain Metastases
por: Joseph A. Bovi
Publicado em: (2018-09-01)